Randomised Controlled TrialiVNSn = 110

Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I)

Tornero C, Pastor E, Garzando MDM, Orduña J, Forner MJ, Bocigas I, Cedeño DL, Vallejo R, McClure CK, Czura CJ, et al.

Frontiers in Neurology · 2022

Key finding

Of the 110 participants who were enrolled and randomly assigned, 97 (nVNS, n = 47; SoC, n = 50) had sufficient available data and comprised the evaluable population.

Condition
Long COVID
Stimulation
iVNS
Evidence tier
Randomised Controlled Trial
Participants
110
View on DOI

Cite this study

Tornero, C., Pastor, E., Garzando, M. D. M., Orduña, J., Forner, M. J., Bocigas, I., Cedeño, D. L., Vallejo, R., McClure, C. K., Czura, C. J., Liebler, E. J., & Staats, P. (2022). Non-invasive Vagus Nerve Stimulation for COVID-19: Results From a Randomized Controlled Trial (SAVIOR I). Frontiers in Neurology, 13. https://doi.org/10.3389/fneur.2022.820864

Related studies in Long COVID

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.